Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion / Q000187:drug effects*; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage; D014700:Verapamil / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D010919:Placebos; D011433:Propranolol; D014700:Verapamil